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The endogenous caspase-8 inhibitor c-FLIPL regulates
ER morphology and crosstalk with mitochondria
ES Marini1, C Giampietri1, S Petrungaro1, S Conti1, A Filippini1, L Scorrano2,3,4,5 and E Ziparo*,1,4,5
Components of the death receptor-mediated pathways like caspase-8 have been identified in complexes at intracellular
membranes to spatially restrict the processing of local targets. In this study, we report that the long isoform of the cellular
FLICE-inhibitory protein (c-FLIPL), a well-known inhibitor of the extrinsic cell death initiator caspase-8, localizes at the endoplasmic
reticulum (ER) and mitochondria-associated membranes (MAMs). ER morphology was disrupted and ER Ca2+-release as well as
ER-mitochondria tethering was decreased in c-FLIP− /− mouse embryonic fibroblasts (MEFs). Mechanistically, c-FLIP ablation
resulted in enhanced basal caspase-8 activation and in caspase-mediated processing of the ER-shaping protein reticulon-4 (RTN4)
that was corrected by re-introduction of c-FLIPL and caspase inhibition, resulting in the recovery of a normal ER morphology and
ER-mitochondria juxtaposition. Thus, the caspase-8 inhibitor c-FLIPL emerges as a component of the MAMs signaling platforms,
where caspases appear to regulate ER morphology and ER-mitochondria crosstalk by impinging on ER-shaping proteins like
the RTN4.
Cell Death and Differentiation (2015) 22, 1131–1143; doi:10.1038/cdd.2014.197; published online 12 December 2014
Cellular FLICE inhibitory proteins (c-FLIP) inhibit death
receptor (DR)-mediated apoptosis, by preventing caspase-8
activation.1 Among the three identified c-FLIP splicing
forms,2,3 c-FLIPS,R were described as cytosolic, whereas
c-FLIPL was also observed in the nucleus. A pool of
membrane-bound c-FLIPL was also described
4 suggesting
that caspase-8/c-FLIPL could re-distribute on stimulation,
leading to a more subtle regulation of caspase-8 activity
depending on substrates localization.5 Furthermore, caspase-
8 itself and Fas-Associated Death Domain adaptor protein
(FADD) were found or were shown to re-loca5lize in local
complexes on ER6–8 and mitochondria,9,10 mediating the
exchange of signals between the two organelles.11–13 Several
molecular platforms containing both membrane-bound pro-
teins and cytosolic apoptosis modulators have been identified
at the ER-mitochondria interface (the so-called mitochondria-
associated membranes or MAMs),14 controlling ER-
mitochondria anchorage as well as lipid metabolism, Ca2+
signaling and apoptosis.15 MAMs have been recently
described as lipid raft-like domains that orient proteins to
promote the ER-mitochondria juxtaposition;16 consequently,
alterations in their composition may profoundly affect the
physical and functional inter-organelle crosstalk. Furthermore,
as mitochondrial and ER membranes are continuously and
concertedly remodeled,17 it is not surprising that membrane-
shaping proteins can also exert a function in regulating the ER-
mitochondria coupling.12,18 Different families of ER-shaping
proteins control the organization of peripheral ER, which
consists of sheet-like cisternae and tubules connected by
three-way junctions.19 Among these, Reticulons (RTN) and
Deleted in Polyposis locus 1 (DP1) proteins cause the ER
membrane to curve and tubulate,20,21 whereas the GTPases
Atlastins (ATL) promote the branching of ER tubules;22 finally,
ER sheet-enriched proteins such as the 63-kDa cytoskeleton-
linking membrane protein (CLIMP63) control the width of ER
cisternae, anchoring the organelle to microtubules and
maintaining its spatial distribution.23,24 Along with other
components of the extrinsic apoptosis, here we described for
the first time the enrichment of c-FLIPL at ER and ER-
mitochondria interface. Furthermore, we observed that ER
structure and tethering to mitochondria are impaired in cells
lacking c-FLIP. Given the importance of membrane-shaping
proteins and MAM complexes in regulating organelles
structure and ER-mitochondria juxtaposition, we focused on
the mechanism underlying this phenotype and we found that
c-FLIPL deficiency induces the caspase-mediated processing
of RTN4, thus affecting organelle shape and coupling to
mitochondria. We therefore concluded that c-FLIPL is a novel
regulator of ER morphology and ER-mitochondria crosstalk.
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Results
c-FLIPL localizes at ER and MAMs. We investigated c-FLIP
subcellular localization by performing cell fractionation and
indirect immunofluorescence. Percoll-purified fractions from
the mouse liver, devoid of cross-contaminations as indicated
by western blotting (WB) analysis of specific markers
(Figure 1a), were assayed. In agreement with previous
evidence,25,26 c-FLIPS was found in the cytosol (Figure 1b).
Conversely, c-FLIPL localized also at the ER+LM (Light
Membranes) and MAMs fractions (Figure 1b). The pattern of
distribution of calnexin (CNX) 27 and AKT,28 both previously
identified at MAMs, further substantiated the specificity
of c-FLIPL subcellular localization (Figures 1a and b).
In homogenates from mouse embryonic fibroblasts (MEFs),
c-FLIPL was similarly retrieved in both ER+LM and crude
mitochondria still containing ER and MAMs as contaminants
(Figure 1c). Confocal analysis corroborated c-FLIP distribu-
tion in MEFs. In the left panel of Figure 1d, yellow discrete
areas represented the ER-mitochondria contact points.
A similar pattern of co-localization was observed for c-FLIP
and mitochondria (Figure 1d, central panel), whereas a wider
overlapping was reported between the ER-protein calreticulin
(CRT) and c-FLIP (Figure 1d, right panel), confirming c-FLIP
distribution at the ER and ER-mitochondria contacts points.
According to biochemical and morphological evidence, we
concluded that ER and MAMs contain c-FLIPL, which is
conversely absent from mitochondria devoid of the
interacting ER.
a
d
b c
Figure 1 c-FLIPL is retrieved at ER and MAMs. (a, b) Proteins (20 μg) from Percoll-purified subcellular fractions of the mouse liver were separated by SDS–PAGE and
immunoblotted with the indicated antibodies, specific for each fraction. The translocase of the mitochondrial outer membrane 20 (TOM20) was used as marker for mitochondria,
the lactate dehydrogenase (LDH) as marker for cytosolic fraction. Calnexin (CNX) is considered as a marker of both ER and MAMs, whereas the long-chain fatty-acid CoA
synthases (FACL4) is MAM-enriched. Distant parts from the same gel were joined at dashed lines. (c) Subcellular fractions and immunoblot analysis from WT MEFs.
(d) Immunofluorescence and confocal analysis of endogenous c-FLIP subcellular localization. WT MEFs were transfected with pDsRed2-mito encoding for the mitochondrial-
targeted fluorescent protein (mtRFP) to label mitochondria and immunostained for the endogenous ER marker calreticulin (CRT) and for c-FLIP. Left and central panels indicate
co-localization of ER with mitochondria, and of mitochondria with c-FLIP. Right panel indicates co-localization of ER and c-FLIP. Boxes denote magnified areas. Scale bar, 20 μm
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Lack of c-FLIPL controls ER integrity and ER-
mitochondria tethering. The subcellular distribution of
c-FLIPL prompted us to investigate its involvement in the
regulation of ER morphology and tethering to mitochondria.
To this aim, WT and c-FLIP− /− MEFs29 transfected with
mitochondria- and ER-targeted fluorescent proteins (respec-
tively mtRFP and ERYFP) were used, and ER and
mitochondrial morphology was investigated by comparing
three-dimensional (3D) reconstructions of volume-rendered
confocal stacks of mtRFP and ERYFP. c-FLIP depletion did
not significantly alter mitochondrial morphology or distribution
(Figure 2a). Conversely, whereas WT cells showed a well-
organized network of interconnected tubules spanning the
whole cytosol (Figure 2b, left panel), c-FLIP− /− cells
displayed a deranged ER, characterized by fragmented and
enlarged cisternae, seemingly to the detriment of reticular ER
at the cell periphery (Figure 2b, central panel). Such defects
were partially restored on c-FLIPL re-introduction in ablated
MEFs (Figure 2b, right panel). To ensure that ER defects
were not a result of transfections toxicity, immunofluores-
cence analysis of the endogenous ER-protein CRT
(Figure 2c) and electron microscopy (EM) analysis were
performed (Figure 2d), confirming the enlargement of ER
cisternae in c-FLIP− /− cells with respect to the tubular ER in
WT MEFs. Fluorescence recovery after photobleaching
(FRAP) of ERYFP was finally used to quantitatively assess
the ER integrity, as the speed with which fluorescence returns
to the photobleached region is dependent on the degree of
ER luminal contiguity.30 In accordance with morphological
evidence, FRAP analysis further substantiated ER impair-
ment and lack of integrity at the cell periphery of c-FLIP− /−
cells (Figure 2e), which were partially restored by c-FLIPL
re-introduction, hence corroborating c-FLIP role in this
phenotype. Confirming the ER fragmentation mainly at the
cell periphery, no major differences in ER luminal contiguity
were observed in the perinuclear area (Figure 2f). In view of
c-FLIPL localization at MAMs and of its involvement in ER
shape, we investigated whether c-FLIP could have a role also
in ER-mitochondria tethering. To address this point, we firstly
measured the ability of crude mitochondria from WT and
c-FLIP− /− MEFs to interact with microsomal components as
CNX. As shown in Figure 2g, crude mitochondria from
ablated MEFs were less contaminated by microsomes than
those isolated from WT, indicating diminished ER-
mitochondria interactions. Successively, we measured the
ER-mitochondria distance by semi-quantitative confocal
microscopy analysis of volume-rendered 3D reconstructions
of z-axis stacks of confocal images of ERYFP and
mtRFP.17,18 Whereas WT MEFs showed several yellow areas
of co-localization, representing the ER-mitochondria contact
points, c-FLIP− /− cells revealed lower ER-mitochondria
juxtaposition (Figure 2h), which was partially restored
on c-FLIPL re-introduction. Quantitatively, Manders’ co-
localization coefficient 31 confirmed these evidence, revealing
~15% reduction in the ER-to-mitochondria tethering in
c-FLIP− /− MEFs, that was counterbalanced by c-FLIPL
re-expression (Figure 2i). The occurrence of inter-organelle
contacts in WTand c-FLIP− /− MEFs was also verified by EM
analysis (Figure 2d).
ER-shaping protein Reticulon-4 is reduced in c-FLIP
ablated cells. Defective ER morphology indicated that
c-FLIPL could have a role in maintaining the ER structure.
To characterize the molecular mechanism involved, we first
compared the expression levels of different ER proteins to
discern whether ER expansion could be related to excessive
ER membrane proliferation. However, we did not detect
significant differences between WTand c-FLIP− /− cells in any
of the tested ER-resident proteins (Figure 3a). We further
compared MFN2 levels, as its involvement in ER-
mitochondria tethering and morphology was previously
reported.18 However, we did not notice major differences
either in MFN2 levels between WTand c-FLIP− /− MEFs, or in
c-FLIPL between WT and MFN2
− /− cells, suggesting a
MFN2-independent mechanism (Figure 3b). As aberrant ER
enlargement observed in c-FLIP− /− cells was similar to ER
defects associated with RTN4 depletion,20 or to overexpres-
sion of ATLs 32 or CLIMP63,23 we compared the expression
levels of these ER-shaping proteins in microsomal fractions
from WT and c-FLIP− /− MEFs (Figures 3c and e). Interest-
ingly, c-FLIP-depleted cells displayed diminished expression
of RTN-4A,B2,1 isoforms (Figure 3c), whereas no significant
variations were observed in CLIMP63 or in ATL1,2 (Figures 3d
and e). Only a slight, but not statistically significant, reduction
in ATL3 was noticed (Figure 3e), indicating the involvement of
RTN4 in ER alterations affecting c-FLIP− /− MEFs. Total
lysates from the two cell lines, besides evidencing the
differences in RTN-4A,B2,1, also revealed additional lower-
molecular weight bands, compatible with cleaved fragments
of this protein and visible predominantly in ablated MEFs
(Figure 3f). Conversely, no extra bands of CLIMP63 were
observed (Figure 3g); therefore, proposing that cleavage
events could affect the RTN4 integrity in c-FLIP− /− MEFs, in
turn the disrupted ER morphology.
TNFα induces RTN4 processing. Previous evidence indi-
cated that caspases and their inhibitors could impinge on
levels of endogenous ER morphogenic proteins. In particular,
caspase-7 was reported to mediate the cleavage of
RTN-4B.33 Owing to the ability of c-FLIP to control the apical
caspase-8, which activates the caspase-7, we investigated
whether increased caspase activation has occurred in cells
lacking c-FLIP, in turn accounting for RTN4 processing. In
agreement with this hypothesis, the basal caspase-8 activity
was enhanced in c-FLIP− /− MEFs (Figure 4a). Successively,
to better characterize the involvement of caspase-8/c-FLIP
axis and extrinsic apoptotic response in RTN4 cleavage and
ER alterations, we exposed c-FLIP− /− cells to increasing
doses of TNFα, known to strongly induce the extrinsic
pathway of apoptosis through caspase activation.29 As
shown, we observed a rapid, but defective cleavage of RTN4
(Figure 4b, upper panel: RTN-4A; lower panel: RTN-4B2,1),
decreasing at higher doses of TNFα despite the dose-
dependent increase in caspase-8 activity (Figure 4c) and
cleavage of caspase-3 and poly-(ADP-ribose) polymerase
(PARP) (Figure 4d), which suggested an efficient activation of
caspase-mediated pathways. As non-neural cells as MEFs
abundantly express RTN-4B2,1 as compared with the little
amount of RTN-4A, evaluation of RTN-4B2,1 was chosen
for the following experiments. As reduction of RTN-4B2,1
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Figure 2 c-FLIPL depletion affects ER morphology and tethering to mitochondria. (a) Left: Representative 3D-reconstructions of mitochondria in MEFs of the indicated
genotype transfected with mtRFP. Right: mean±S.E.M. (n= 4, 25 cells per experiment) of data from a. (b) Representative 3D-reconstructions of ER in MEFs of the indicated
genotype co-transfected with ERYFP and with plasmids encoding for c-FLIPL or for the empty vector. ‘c-FLIP’ indicates c-FLIPL re-introduction in depleted MEF. Scale bar, 25 μm.
(c) Immunofluorescence analysis of the resident ER protein CRT in WTand c-FLIP− /− MEFs. (d) Representative EM images of ER and ER-mitochondria contact points in WT
and c-FLIP− /− cells. Scale bar, 0.54 μm in the upper, right panel; 0.35 μm in other panels. Arrows indicate ER-mitochondria proximity. (e, f) Fluorescence recordings from real-
time sequence of ERYFP FRAP in c-FLIP− /− and WT MEFs at the cell periphery (e) and in the perinuclear region (f). The histogram reported mean± S.E.M. (n= 5, 10 cells per
experiment) of data from e (**P≤ 0.001; ***P≤ 0.0001). In e, f, 16-μm2 regions were photobleached for a total of 3 s, using 100% laser power of the 488 nm line. The post-
bleaching images were taken for a total of 120 s. ‘c-FLIP’ indicates c-FLIPL re-introduction in depleted MEF, ‘EV’ the empty vector. (g) WB of the indicated proteins in crude
mitochondrial fractions (20 μg) from WTand c-FLIP− /− MEFs. (h) Representative 3D-reconstructions of ER and mitochondria in MEFs of the indicated genotype co-transfected
with mtRFP, ERYFP and the reported plasmids. Yellow areas indicate that organelles are closer than 270 nm. Scale bar, 25 μm. (i) Mean± S.E.M. (n= 5, 10 cells per experiment)
of interaction data from h (***P≤ 0.0001)
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cleavage at increasing TNFα doses (Figure 4b) or at longer
time points (Figures 4e and f) occurred concomitantly to the
formation of a higher-weight form of RTN-4B2,1 (indicated by
the asterisk in the less-exposed lane) compatible with the
phosphorylated form of the protein, we hypothesized that in
our model RTN-4B2,1 processing could be prevented by an
unidentified TNFα-induced phosphorylation event. Interest-
ingly, cyclin-dependent kinases 1/2 (CDK1/2)-mediated
phosphorylation of RTN-4B was reported to negatively
control RTN4 processing.33 In accordance with our hypoth-
esis, co-treatment of c-FLIP− /− MEFs with TNFα and the
CDK1/2 pharmacological inhibitor JNJ-7706621 lowered the
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Figure 3 Evaluation of different ER markers in WT and c-FLIP-ablated cells. (a) Total lysates (50 μg) from WT and c-FLIP− /− MEFs were separated by SDS–PAGE and
immunoblotted for different ER markers. (b) Upper panel: representative WB analysis of MFN2 level in total lysates from WT and c-FLIP− /− MEFs (n= 4). Lower panel:
representative WB analysis of c-FLIPL level in total lysates from WTand MFN2
− /− MEFs (n= 3). (c, d) Representative WB analysis of expression levels of RTN-4A and -B2,1
(c) and CLIMP63 (d) in ER fractions isolated from WT and c-FLIP− /− MEFs. The same amount of proteins was used and protein loading was controlled by evaluating the
expression of the ER-resident protein BAP31. Histograms indicate the mean± S.E.M. of full length, ER+LM-associated RTNs densitometric analysis (n= 3 for RTN-4A; n= 3 for
RTN-4B2,1). (e) WB analysis of expression levels of ATL1,2,3 in ER fractions. BAP31 was used as loading control. The densitometric analysis reported in the histogram,
represented the mean± S.E.M. (n= 3) of ATL3 level. (f, g) WB analysis of RTN-4A,B2,1 (f) and CLIMP63 (g) levels in total lysates from c-FLIP
− /− and WT MEFs. Histograms
indicate the mean±S.E.M. of full-length RTN densitometric analysis (n= 3 for RTN-4A; n= 6 for RTN-4B2,1) In c, d, f broken lines indicate where a lane was deleted
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accumulation of the higher-weight form of RTN-4B2,1 and
increased the formation of cleavage fragments with respect to
c-FLIP− /− cells treated with TNFα alone (Figure 4g). We also
observed mild RTN-4B2,1 cleavage in WT cells on TNFα
treatment. Such cleavage increased when TNFα was
combined with the de novo protein synthesis inhibitor
cycloheximide (data not shown). Together our data highlight
a role for TNFα-induced caspase activation in RTN4
cleavage, in c-FLIP-deficient cells as well as in their WT
counterpart.
A caspase-mediated pathway is involved in RTN4 altera-
tions and influences ER morphology and tethering to
mitochondria. As already reported in other experimental
models,34,35 we verified that c-FLIP ablation in MEFs
enhanced the basal caspase-8 activity (Figure 4a), which
was restored by both the specific caspase-8 inhibitor zIETD
and c-FLIPL re-introduction (Figure 5a). To confirm the
involvement of caspases in TNFα-mediated RTN4 processing
in c-FLIP− /− cells, zIETD and the pan-caspases inhibitors
zVAD were used. Although both inhibitors were efficient in
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Figure 4 Caspase activation impacts on RTN4 levels in c-FLIP− /− MEFs. (a) Basal caspase-8 activity was measured in c-FLIP− /− and WT MEFs. Mean±S.E.M. (n= 7)
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reducing the basal RTN4 proteolysis, even though to a
different extent (Figure 5b), zVAD efficaciously diminished
also the TNFα-induced RTN-4B2,1 processing (Figure 5c).
This evidence further corroborated the role of caspases and
components of DR-mediated pathway in controlling the RTN4
cleavage. In view of the essential role of reticulons in ER
tubulogenesis, as well as of the involvement of caspases in
RTN4 regulation, we wondered whether the altered ER
morphology of c-FLIP− /− cells could be associated with the
caspase-dependent RTN4 cleavage. To test this hypothesis,
ER morphology and ER-mitochondria tethering of c-FLIP− /−
MEFs pre-treated with zVAD were compared with those of
WT and c-FLIP− /− cells exposed to the vehicle DMSO.
Strengthening the proposed model, semi-quantitative con-
focal microscopy analysis of volume-rendered 3D reconstruc-
tions of z-axis stacks of confocal images of WTand c-FLIP− /−
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cells transfected with ERYFP revealed that caspase-inhibition
was sufficient to rescue the ER morphology of c-FLIP− /−
MEFs (Figure 5d). Moreover, as estimated by measuring the
quantitative Manders’ co-localization coefficient, zVAD was
also efficient in restoring the ER-mitochondria distance of
c-FLIP− /− MEFs to levels comparable to those of WT
(Figure 5e and f), hence underlying the potential role of
caspases in regulating membrane-localized proteins and
ER-mitochondria interactions.
c-FLIP ablation results in disturbed Ca2+ signaling. Integ-
rity of ER and ER-mitochondria contact points have been
demonstrated to be crucial for Ca2+ signaling.36 In view of the
role of c-FLIPL at the ER and MAMs, we investigated its
involvement in Ca2+ exchange between the two organelles.
We firstly compared the increase in cytosolic Ca2+ concen-
tration ([Ca2+]c) in Fura-2AM-loaded WTand c-FLIP
− /−MEFs
on treatment with the sarcoplasmic-endoplasmic reticulum
Ca2+ ATPase (SERCA) inhibitor thapsigargin (TG), causing
the passive ER discharge, and with ATP which induces ER
Ca2+ release from inositol 1,4,5-trisphosphate (IP3)-sensitive
stores. EGTA was added to all solutions to assess only
intracellular calcium fluxes. c-FLIP− /− MEFs displayed
severely blunted ER Ca2+ release in response to both TG
and ATP (Figures 6a and b). In addition, as [Ca2+]c is buffered
by mitochondria, along with the blunted ER Ca2+ release, in
Rhod-2AM loaded c-FLIP− /− cells also the mitochondrial
Ca2+ peak evoked by ATP was significantly lower than that in
WT (Figure 6c). Nevertheless, such defects were not restored
by c-FLIPL re-introduction, as we did not observe any
amelioration in either ER Ca2+ release (Figure 6d) or
mitochondrial Ca2+ entry (Figure 6e) in c-FLIP− /− cells
re-expressing c-FLIPL with respect to c-FLIP
− /− MEFs
transfected with the EV. According to our data, c-FLIP− /−
MEFs displayed reduced ER-mitochondria juxtaposition and
diminished Ca2+ exchange. We therefore wondered whether
the reduced ability of ER and mitochondria to exchange
signals and calcium could impact on Ca2+-mediated apopto-
sis. In agreement with this hypothesis, cells lacking c-FLIP
were more resistant than WT to hydrogen peroxide (H2O2),
which is known to induce a Ca2+-dependent apoptotic
response (Figure 6f).37 Conversely, c-FLIP− /− MEFs were
as susceptible as WT to staurosporine (STS), which activates
the mitochondrial pathway, but much more sensitive to DR-
stimulation induced by TNFα, as previously reported
(Figure 6g). Altogether our data demonstrate that c-FLIP
ablation loosens ER-mitochondria juxtaposition, lowering
Ca2+ transfer to mitochondria and impacting on sensitivity
to Ca2+-dependent apoptosis.
Calcium chelation in WT MEFs induces ER changes. TG-
induced ER Ca2+ release is an indirect measure of ER Ca2+
content at the steady state. According to our data suggesting
diminished Ca2+ levels and Ca2+ exchange in cells lacking
c-FLIP, we speculated that these differences could directly
contribute to the observed ER defects. We therefore tested
whether the chelator of free, cytosolic calcium 1,2-Bis(2-
aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis
(acetoxymethyl ester) (BAPTA-AM) could modify the overall
ER structure in WT and c-FLIP− /− MEF. Unexpectedly,
BAPTA-AM affected ER shape and RTN-4B1,2 integrity of
the two cell lines. These effects were more evident in WT
MEFs (Figure 7a, left panels), leading to ER enlargement and
fragmentation and resembling ER defects of c-FLIP− /−
MEFs, which were only marginally affected by Ca2+ chelation
(Figure 7a, right panels). WB analysis further revealed that
BAPTA-AM caused RTN-4B1,2 processing in WT cells, aug-
menting fragments formation in also c-FLIP− /− cells. Despite
these effects, BAPTA-AM did not modulate c-FLIPL levels in
WT cells, nor induced PARP cleavage (Figure 7b), suggesting
a caspase-independent mechanism. Concordantly, whereas
zVAD efficaciously diminished the basal RTN-4B1,2 cleavage
in c-FLIP− /− MEFs (Figure 7c), it did not abrogate the BAPTA-
AM-induced RTN4 processing in either of the two cell lines
(respectively, in Figures 7c and d). These data suggest that, in
c-FLIP− /− cells, ER effects and RTN4 processing could be
also directly associated with disturbed calcium levels, besides
to the caspase-dependent pathway.
Discussion
Components of DR signaling as caspase-8 have been
identified on ER and mitochondria, suggesting that target
specificity may depend on cellular compartments.5 In this
study, we report that a fraction of the caspase-8 inhibitor
c-FLIPL is enriched at the ER and MAMs. Along with other
MAM-proteins, whose ablation affects ER and mitochondrial
morphology or their coupling,18,37,38 here we demonstrate that
c-FLIP deficiency in MEFs impacts on ER organization,
causing enlargement of ER sheets to the detriment of tubular
structures. The relative amount of the ER-shaping proteins
RTN/DP1 and CLIMP63 was described to influence the cell-
type-specific ratio of sheets to tubules in mammalian cells.39
Jozsef et al.40 demonstrated that RTN4 deficiency in MEFs is
sufficient to convert ER tubules to cisternal structures, without
affecting other ER-shaping factors or ER-resident proteins.40
Interestingly, we found decreased expression of RTN-4A,B2,1
in c-FLIP− /− MEFs, whereas no major differences were
observed in other ER-shaping proteins or in ER proteins,
confirming that ER defects of c-FLIP− /− MEFs were not
related to variations in the overall ER content or to excessive
CLIMP63 expression or ATL-mediated fusion.32 As caspase-7
was formerly reported to process the RTN-4B on its
cytoplasmic tail on apoptotic induction,33 we hypothesized
that ER defects observed in c-FLIP− /− cells could be
associated with a deregulated, caspase-dependent proces-
sing ofRTN4occurring in cells lacking the inhibitor of caspase-8.
In agreement with our hypothesis, here we demonstrate that
c-FLIP− /− MEFs show an increased basal RTN4 processing,
and that TNFα is sufficient to accelerate its cleavage.
Interestingly, despite TNFα promptly induced a dose-
dependent activation of caspase-8 and caspase-3, we
observed only an initial cleavage of RTN4, decreasing at
higher doses of TNFα or at longer time points, concomitantly to
the accumulation of an higher-weight form of RTN-4B2,1. As
Cyclin-dependent kinases 1/2 (CDK1/2) phosphorylate RTN4,
abrogating its cleavage and inducing the accumulation of an
higher-weight phosphorylated form, we hypothesized that the
incomplete RTN4 processing could be associated with
a CDK-mediated phosphorylation event. In accordance with
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Figure 6 c-FLIP absence alters Ca2+ homeostasis and Ca2+-dependent apoptosis. (a) Fura-2AM recordings of cytosolic Ca2+ ([Ca2+]c) after passive discharge of ER Ca
2+
stores induced by 1 μM TG in MEFs of the indicated genotype. Upper panel: maximum Ca2+ concentrations in bar charts. Mean± S.E.M. of n= 70–100 cells. Lower panel:
changes in Ca2+ concentrations shown as representative traces. (b) Fura-2AM recordings of cytosolic Ca2+ ([Ca2+]c) after active ER Ca
2+ release induced by 100 mM ATP in
MEFs of the indicated genotype. Upper panel: maximum Ca2+ concentrations in bar charts. Mean± S.E.M. of n= 70–100 cells. Lower panel: changes in Ca2+ concentrations
shown as representative traces. (c) Rhod-2AM recordings of mitochondrial Ca2+ entry (F1/F0) after active ER-to-cytosol Ca2+ release induced by 100 mM ATP in MEFs of the
indicated genotype. Upper panel: maximum Ca2+ concentrations in bar charts. Mean± S.E.M. of n= 70–100 cells. Lower panel: changes in Ca2+ concentrations. In a–c
*P≤ 0.05; **P≤ 0.001; ***P≤ 0.0001. (d) Fura-2AM recordings of cytosolic Ca2+ ([Ca2+]c) after active ER Ca2+ release induced by 100 mM ATP in c-FLIP− /− MEFs transfected
with the indicated plasmids. (e) Rhod-2AM recordings of mitochondrial Ca2+ entry (F1/F0) after active ER-to-cytosol Ca
2+ release induced by 100 mM ATP in c-FLIP− /− MEFs
transfected with the indicated plasmids. (f) Representative WB analysis of total lysates (40 μg) from MEFs of the indicated genotype, on treatment with H2O2 1 mM for 3 h.
Apoptosis was investigated evaluating cleavage of PARP and caspase-3. (g) Representative WB analysis of total lysates (40 μg) from MEFs of the indicated genotype, on
treatment with STS (2 μM) for 3h and TNFα 10 ng/ml for 2 h. Apoptosis was investigated evaluating cleavage of PARP and caspase-3. (n= 5 for H2O2 treatment; n= 3 for STS
and TNFα treatments)
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previous evidence, c-FLIP− /− MEFs exposed to TNFα in
combination with the CDK1/2 inhibitor JNJ-7706621 showed
increased RTN-4B fragments formation and disappearance of
the higher-weight form. Consistent with the reported role of
caspases in RTN4 processing, we confirmed that, RTN4
cleavage was caspase-dependent, as in c-FLIP− /− MEFs the
pan-caspase inhibitor zVAD effectively decreased basal and
TNFα-induced RTN4 proteolysis. Interestingly, along with
blocking basal RTN4 processing, zVAD ameliorated ER
morphology of c-FLIP− /− MEFs, strengthening the nexus
between caspases and mechanisms of ER shaping. As MAM
complexes control ER-mitochondria juxtaposition either by
linking the two organelles,18 or by affecting mitochondrial and
ER shape,12 we successively investigated whether caspases
and c-FLIP could exert a role in the maintenance of ER
mitochondria distance in c-FLIP− /− cells. In agreement with
our hypothesis, we demonstrate that in, c-FLIP− /− MEFs,
rescue of a proper ER organization induced by both c-FLIPL
re-introduction and zVAD also restores the ER-mitochondria
juxtaposition to levels comparable to those ofWT. Impaired ER
and mitochondrial morphology and tethering ultimately affect
the ER-to-mitochondria Ca2+ transfer. We therefore focused
also on c-FLIP involvement in Ca2+ homeostasis and found
decreased Ca2+ exchange and deregulated sensitivity to Ca2+
dependent apoptosis in c-FLIP− /− cells. As already demon-
strated, we confirmed that c-FLIP depletion considerably
sensitized c-FLIP-deficient cells to extrinsic apoptosis induced
by TNFα, but only marginally influenced the apoptotic
response to STS, which stimulates the mitochondrial
pathway.29 Here we also demonstrate that c-FLIP deficiency
protects against H2O2-mediated cell death. As H2O2 requires
ER-mitochondria Ca2+ transfer,37 this result correlates with the
impaired inter-organellar Ca2+ exchange. Despite c-FLIP− /−
MEFs showed lower IP3- and TG-induced ER-to-cytosol Ca
2+
release and mitochondrial Ca2+ entry than WT counterpart,
such defects were not rescued by c-FLIPL re-introduction,
suggesting possible additional mechanisms not directly
relying on c-FLIP expression. To address this point, we
evaluated whether ER derangement observed in c-FLIP− /−
MEFs could also be associated with the deregulated Ca2+
signaling in a c-FLIP-independent way. Ferrari et al.41
previously demonstrated that on apoptosis induction, ER
remodelling was not consequent to caspases activation, but
controlled by chelation of Ca2+. Surprisingly, in our experi-
mental model, the Ca2+ chelator BAPTA-AM induced ER
enlargement, concomitantly to RTN-4B2,1 cleavage inWT cells,
Figure 7 Chelation of cytosolic calcium in WT MEFs modifies ER shape and RTN4 integrity. (a) Immunofluorescence analysis and representative 2D-reconstructions of the
resident ER protein CRT in WTand c-FLIP− /− MEFs treated with BAPTA-AM 5 μM or with the vehicle DMSO. Scale bar, 25 μm. (b) Evaluation of RTN-4B2,1 by WB analysis in
WTand c-FLIP− /− MEFs treated for 3 h with BAPTA-AM 5 μM or with the vehicle DMSO as indicated. (c, d) WB analysis of RTN-4B2,1 fragments, respectively, in c-FLIP
− /−
(c) and WT (d) MEFs treated for 3 h with BAPTA-AM 5 μM alone or in combination with the pan-caspase inhibitor zVAD.
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and worsened RTN-4B2,1 fragmentation in c-FLIP
− /− MEFs.
These effects were more pronounced in WT than in c-FLIP− /−
cells, probably as a consequence of the different Ca2+ content
of the two cell lines. To better investigate whether modulation of
Ca2+ levels could modify the ER organization independently of
c-FLIP and caspases, we evaluated c-FLIPL levels and PARP
cleavage as a measure of caspase activation. Interestingly,
BAPTA-AM neither modulated c-FLIPL in WT MEFs, nor
induced RTN-4B2,1 cleavage via caspases. Nevertheless,
although caspase activation was not described as necessary
to ER remodeling during apoptosis,41 we cannot exclude that
the increased caspase-8 activity observed in c-FLIP− /− cells at
basal conditions could impinge on RTN4 cleavage and ER
integrity, in turn emphasizing the role of caspase-mediated
processing of RTN4. To summarize, in addition to showing
c-FLIPL at the ER and MAMs, in this paper we demonstrate its
relevance in modulating ER morphology and tethering to
mitochondria. We also provide evidence of a new role for
caspases in ER structure modulation via processing of RTN4.
Although the importance of RTNs transmembrane domains in
ER tubulation was firstly described,20,21 modifications in the
intrinsically unstructured, cytosolic regions of RTN4 42 have
been reported to influence the variable functions of RTNs or
specific interactions.20,40 We can therefore speculate that
caspases, acting on exposed regions of RTN4, might disturb
the localization43 or the ability of ER-shaping proteins to form
complexes and interact with cytoskeletal components or
organelles.44 Concluding, the present study highlights addi-
tional non-apoptotic roles for the death-receptor pathway, a
frame in which c-FLIPL and caspases emerge as new factors in
the maintenance of ER homeostasis.
Materials and Methods
Cell cultures and reagents. Wild type (WT) and c-FLIP− /− MEFs were a
generous gift of Tak W. Mak (Amgen Institute, Toronto, Canada). MEFs were
cultured in DMEM, enriched with 10% fetal bovine serum, glutamine (2 mmol/l),
sodium pyruvate (1 mmol/l) and non-essential amino acids, in the presence of
penicillin (100 U/ml) and streptomycin (100 μg/ml). The Insolution Caspase-8
inhibitor II, indicated as Z-IE(OMe)TD(OMe)-FMK (zIETD), was purchased from
Calbiochem (San Diego, CA, USA). Cells were treated for 24 h with zIETD 40 μM or
with the vehicle DMSO. The N-Benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluoromethyl
ketone (zVAD-FMK) was purchased from Sigma-Aldrich (St Louis, MO, USA). Cells
were treated for 24 h with zVAD 40 μM or with the vehicle DMSO. Where indicated,
JNJ-7706621 was added to cell cultures. After 1 h pre-treatment, TNFα was added.
JNJ-7706621 was synthesized by the Cancer Therapeutics Research Team
(Johnson & Johnson Pharmaceutical Research and Development, LLC).
Transfections with pDsRed2-Mito (Clontech laboratories INC—Palo Alto, CA, USA),
pEGFP-ER (Clontech) and pBluescript or c-FLIPL plasmid (kindly provided by
M. Peter (The Ben May Institute for Cancer Research, University of Chicago,
Chicago, IL USA) were performed using Transfectin reagent (BioRad, Hercules, CA,
USA) at 2 μg/μl, or Lipofectamin Reagent (Invitrogen, San Giuliano Milanese, Italy) at
4 μg/μl, according to the manufacturer’s instructions. Where indicated, BAPTA-AM
(Sigma-Aldrich) 5 μM or the vehicle DMSO was added to cell cultures for 3 h
at 37 °C and ER morphology and WB analysis of RTN4 were performed.
Subcellular fractionation. Whole mouse liver from adult CD1 mice or WT
and c-FLIP− /− MEFs obtained from four, confluent, 500 cm2 petri dishes was
washed twice with PBS, re-suspended in isolation buffer (IB, 200 mM sucrose,
1 mM EGTA-Tris, and 10 mM Tris-MOPS, pH 7.4), and then broken up by dounce
homogenization. Purified fractions were obtained according to Frezza et al.45
Protein concentration was determined by micro BCA assay (Pierce Rockford, USA)
and 20 μg of protein extract was separated by SDS–PAGE and immunoblotted
for the indicated antibodies. All animal procedures were conducted in compliance
with the Italian Ministry for Health guidelines.
Immunoblotting. Cells were collected and lysed in lysis buffer (Cell Signaling
Technology, Danvers, MA, USA) in the presence of complete protease-inhibitor
mixture (Sigma-Aldrich). Protein concentration was determined by micro BCA assay
(Pierce, Rockfod, IL, USA) and the indicated proteins were separated by SDS–
PAGE and transferred onto polyvinylidene difluoride (PVDF, BioRad) or
nitrocellulose membranes (Amersham Bioscience, Piscataway, NJ, USA).
Membranes were probed using the following antibodies: anti-β-actin (1:10 000,
Sigma-Aldrich); anti-calnexin (1:2000, Abcam, Cambridge, UK); anti-Tom20
(1:10000, Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti- lactate
dehydrogenase (LDH) (1:2000, Rockland); anti-long-chain fatty-acid CoA synthases
(FACL4) (1:500, Santa Cruz Biotechnology); anti-calreticulin (CRT) (1:1000,
Abcam); anti-c-FLIP Dave II clone (1:800, Alexis, Lausen, Switzerland);
anti-RTN4 (1:1000, Abcam); anti-CLIMP63 (1:1000, Proteintech Group, Chicago,
IL, USA); anti-cleaved caspase-3 (1:500, Cell Signaling Technology) and anti-PARP
(1:1000; Cell Signaling Technology).
Imaging. For confocal imaging and analysis of the morphology and tethering of
ER and mitochondria, cells seeded on 24-mm round glass coverslips and incubated
in Hanks balanced salt solution (HBSS), supplemented with Hepes 10 mM, were
placed on the stage of a Nikon Eclipse TE300 inverted microscope equipped with a
spinning-disk PerkinElmer Ultraview LCI confocal system, a piezoelectric z-axis
motorized stage (Pifoc, Physik Instrumente, Germany) and an Orca ER 12-bit
charge-coupled device camera (Hamamatsu Photonics, Japan). Cells expressing
ERYFP and/or mtRFP were excited using the 488 nm or the 543 nm line of the
HeNe laser (PerkinElmer, Waltham, MA, USA) by using a × 60 1.4 NA Plan Apo
objective (Nikon Corporation, Japan). For confocal z-axis stacks, images separated
by 0.2 μm along the z-axis were acquired. To evaluate ER morphology and
ER-mitochondria tethering on zVAD or BAPTA treatment a Leica confocal
microscope (Laser Scanning TCS SP2, Leica Microsystems Heidelberg GmbH,
Mannheim, Germany) equipped with Ar/ArKr and He/Ne lasers and with a × 40 oil
1.40 plan Apo immersion objective was utilized. Analysis of the interactions between
ER and mitochondria was performed with the software ImageJ. Deconvolution,
2D- and 3D-reconstruction and surface rendering were realized using the VolumeJ
plugin of ImageJ. Analysis of the interaction between ER and mitochondria was
performed using Manders’ colocalization coefficient.31
Fluorescence recovery after photobleaching. Cells were plated and
transfected with ERYFP as previously described. After 48 h they were incubated in
HBSS and placed on the stage of a laser scanning microscope (TCS SP5, Leica).
Using the LasAF software (Leica), 16-μm2 regions were manually defined to be
bleached. To bleach the YFP fluorescence, one z-plane was bleached for a total of
3 s using 100% laser power of the 514 nm laser line with a × 63, 1.4NA objective.
The post-bleaching images were taken at 0.937 s intervals for a total of 120 s.
Intensities of the photobleached regions were measured and normalized to the
intensities of the same region before photobleaching.
Ratiometric measurement of cytosolic Ca2+ concentration. A total
of 15x104 WTand c-FLIP− /− MEFs were seeded on 35 mm Petri dishes. Twenty-four
hours after seeding, cells were incubated for 45 min at 37 °C in culture medium
containing Fura-2AM 3.5 μM (Invitrogen), which is a ratiometric fluorescent dye
binding to free intracellular calcium. Cells were then washed free of Fura2-AM and
Hanks balanced solution (HBSS, 130 mM NaCl, 5.2 mM KCl, 1 mM MgCl2, 10 mM
glucose, 10 mM HEPES, pH 7.4) was added. EGTA was added to all solutions.
Dishes were placed into a culture chamber at 37 °C on the stage of an inverted
fluorescence microscope (Nikon TE2000E) and connected to a cooled CCD camera
(512B Cascade; Roper Scientific, Princeton Instruments, Trenton, NJ, USA). Samples
were illuminated alternately at 340 and 380 nm using a random access
monochromator (Photon Technology International, Birmingham, NJ, USA) and
emission was detected using a 510 nm emission filter. Images were acquired (1-ratio
image/s) using Metafluor software (Universal Imaging Corporation, Downingtown, PA,
USA). Calibration was obtained at the end of each experiment by maximally
increasing intracellular Ca2+-dependent Fura-2AM fluorescence with ionomycin
salt solution (Sigma-Aldrich) 5 μM, followed by recording minimal fluorescence in a
Ca2+-free medium. Ca2+ concentration was calculated according to the previously
described formulas.46 Where indicated, c-FLIP− /− cells were transiently transfected
with pBluescript or c-FLIPL plasmids and ER-to-cytosol Ca
2+-fluxes were measured in
Fura-2AM-loaded cells.
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Measurement of mitochondrial Ca2+concentration. A total of
15 × 104 WT and c-FLIP− /− MEFs were seeded on 35 mm, high, glass bottom
Petri dishes. Twenty-four hours after seeding, cells were incubated for 1 h at 37 °C
in culture medium containing Rhod2-AM 6 μM (Invitrogen). The ester forms of this
calcium indicator are cationic, resulting in potential-driven uptake into mitochondria.
Cells were then washed with standard medium and EGTA-containing HBSS at room
temperature. Single-cell fluorescence was excited at 545 nm using a random access
monochromator (Photon Technology International) and emission was detected using
a 580 nm emission filter. Images of the emitted fluorescence, obtained with a × 60
oil objective, were collected using Metafluor software (Universal Imaging
Corporation). Where indicated, c-FLIP− /− cells were transiently transfected with
pBluescript or c-FLIPL plasmids and mitochondrial Ca
2+ entry were measured in
Rhod-2AM-loaded cells.
Evaluation of caspase-8 activity. Caspase-8 activitiy was measured
by the previously tested47 colorimetric FLICE/Caspase-8 Assay kit (BioVision/Vinci-
Biochem, Firenze, Italy) according to the manufacturer’s protocol. Levels of
caspase-8 activation were normalized by total protein concentration.
Transmission electron microscopy. For ultrastructural observation, cell
monolayers were fixed in 2.5% glutaraldehyde (Electron Microscopy Science,
Pennsylvania, USA) and in 0.1% cacodylate buffer (Electron Microscopy Science),
postfixed in 1% osmium tetroxide (Electron Microscopy Science) and then treated
with 1% tannic acid (Acros Organics, New Jersey, NJ, USA). Dehydrated in
ethanol (Carlo Erba), cells were detached from the plastic dish by a brief
treatment in 1% toluene (Carlo Erba). The pelleted monolayer was then incubated
in a solution of 50% toluene and 50% EPON 812 (Electron Microscopy Science)
and finally processed for conventional EPON 812 embedding. Ultra-thin
sections were cut in a Leica Ultracut R ultramicrotome, contrasted for 10 min in
1% acid tannic and successively in 1% lead hydroxide (Società Italiana
Chimici, Rome, Italy) and then viewed in a Hitachi 7000 transmission electron
microscope.
Statistical analysis. Values are expressed as mean±S.E. Statistical
evaluation was performed by Student's t-test analysis and a value of P≤ 0.05
was considered statistically significant.
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